Coronavirus tally: Global cases of COVID-19 top 248.7 million and U.S. cancels Emergent BioSolutions vaccine deal


The global tally for the coronavirus-borne illness climbed above 248.7 million on Friday, while the death toll edged above 5.03 million, according to data aggregated by Johns Hopkins University. The U.S. continues to lead the world with a total of 46.3 million cases and 751,555 deaths. The U.S. is still averaging about 1,200 deaths a day, according to a New York Times tracker, although cases and hospitalizations are declining. The federal government has canceled a multimillion dollar deal with Emergent BioSolutions EBS, +0.04%, a Maryland-based vaccine manufacturer with facilities in Baltimore that were found to have produced millions of contaminated Johnson & Johnson JNJ, -0.28% vaccine doses this spring,the Washington Post reported. Emergent disclosed the development Thursday in a conference call discussing its latest financial results, the Post reported. Emergent said it will forgo about $180 million due to the contract’s termination, according to the Post.
India is second by cases after the U.S. at 34.3 million and has suffered 459,873 deaths. Brazil has second highest death toll at 608,671 and 21.8 million cases. In Europe, Russia has the most fatalities at 239,943 deaths, followed by the U.K. at 141,826.

This article was originally published by Read the original article here.

Previous articleThe Wall Street Journal: AT&T, Verizon to delay rollout of new 5G frequency over FAA’s safety concerns
Next articleGerman industrial production falls a second straight month on supply woes


Please enter your comment!
Please enter your name here